However, a recent study discovered that interruption of C–C motif chemokine ligand 2 (CCL2) inhibition was associated with increased cancer cell mobility and neovascularization, leading to accelerated metastasis and cancer death (88). The gene discussed is CCL2; the disease is cancer.